Ticker
ADIL

Price
0.40
Stock movement down
-0.01 (-2.70%)
Company name
Adial Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
10.84M
Ent value
7.42M
Price/Sales
-
Price/Book
2.00
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-79.81%
3 year return
-30.37%
5 year return
-
10 year return
-
Last updated: 2023-03-22
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
March 31, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
March 7, 2023

iO Charts is a Seeking Alpha partner

DIVIDENDS

ADIL does not pay dividends or no data was received
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
February 24, 2023

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
November 14, 2022

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book2.00
EV to Sales-
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
August 22, 2022

iO Charts is a Seeking Alpha partner

Onward Phase III Clinical Trial of Adial Pharmaceutical’s AD04, a treatment for Alcohol Abuse Disorder, was completed in early 2022. Read about the stock outlook here.
August 22, 2022

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count26.85M
EPS (TTM)-0.61
FCF per share (TTM)-0.46

Income statement

Loading...
Income statement data
Revenue (TTM)0.00
Gross profit (TTM)0.00
Operating income (TTM)-16.06M
Net income (TTM)-15.70M
EPS (TTM)-0.61
EPS (1y forward)-0.56

Margins

Loading...
Margins data
Gross margin (TTM)-
Operating margin (TTM)-
Profit margin (TTM)-

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash5.75M
Net receivables0.00
Total current assets6.77M
Goodwill248.97K
Intangible assets4.62K
Property, plant and equipment0.00
Total assets7.74M
Accounts payable278.20K
Short/Current long term debt220.25K
Total current liabilities1.33M
Total liabilities2.33M
Shareholder's equity5.41M
Net tangible assets4.70M

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-11.81M
Capital expenditures (TTM)0.00
Free cash flow (TTM)-11.81M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-290.17%
Return on Assets-202.74%
Return on Invested Capital-287.25%
Cash Return on Invested Capital-216.11%
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
August 17, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
August 16, 2022

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open0.41
Daily high0.43
Daily low0.40
Daily Volume143K
All-time high8.33
1y analyst estimate8.50
Beta0.59
EPS (TTM)-0.61
Dividend per share-
Ex-div date-
Next earnings date15 May 2023

Downside potential

Loading...
Downside potential data
ADILS&P500
Current price drop from All-time high-95.15%-17.92%
Highest price drop-97.56%-56.47%
Date of highest drop12 Dec 20229 Mar 2009
Avg drop from high-72.32%-11.51%
Avg time to new high106 days13 days
Max time to new high1054 days1805 days
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
July 20, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
June 14, 2022

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
ADIL (Adial Pharmaceuticals Inc) company logo
Marketcap
10.84M
Marketcap category
Small-cap
Description
Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.
Employees
16
Investor relations
-
SEC filings
CEO
William B. Stilley
Country
USA
City
Charlottesville
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
May 16, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
May 16, 2022

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
February 11, 2022

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
January 24, 2022

iO Charts is a Seeking Alpha partner

COMPANY NEWS
All newsPress releases
Secured meetings with U.S. and European regulatory agencies Advancing partnership activities in both the U.S. and Europe Ended 2022 fiscal year with cash and cash equivalents of $4.0 million CHARLOTTE...
March 30, 2023
The Keswick Group is led by experienced pharmaceutical business development executive, Tony GoodmanCHARLOTTESVILLE, Va., March 21, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; A...
March 21, 2023
CHARLOTTESVILLE, Va., March 08, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing ...
March 8, 2023
Adial Pharmaceuticals Inc (NASDAQ: ADIL) shares are trading higher after an update on its regulatory strategy for AD04, the company's lead compound for Alcohol Use Disorder (AUD). The company said add...
March 7, 2023
ADial Pharmaceuticals stock soars after alcohol disorder treatment clinical trial news, Squarespace rises after estimate-beating results.
March 7, 2023
Company to pursue path toward U.S. and European approvals; Type C meeting with FDA confirmed for Q2 2023; plans in place to meet with multiple European regulatory authoritiesAdial in discussions with ...
March 6, 2023
Management to provide an update on its regulatory and partnering strategy for the United States and EuropeCHARLOTTESVILLE, Va., March 02, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ...
March 2, 2023
With the business potentially at an important milestone, we thought we'd take a closer look at Adial Pharmaceuticals...
February 28, 2023
CHARLOTTESVILLE, Va., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing t...
February 27, 2023
CHARLOTTESVILLE, Va., Feb. 24, 2023 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), a clinical-stage biopharmaceutical company focused on developing t...
February 24, 2023
Next page
Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
October 21, 2021

iO Charts is a Seeking Alpha partner

Get the latest news and real-time alerts from Adial Pharmaceuticals, Inc. (ADIL) stock at Seeking Alpha.
September 28, 2021

iO Charts is a Seeking Alpha partner